Pharmacy Newspaper June 2012

Page 1

i50

L ERJE WAT 5

i4 i46 GN

i44

Y C EM OT CAD A

3

C

i36

i38 NSULTA CO i31

3

3

DR HAR SC 2

i30

C ULTA CONS 5

S SALU

C i29 2 ULTA 7 N i3 CONS 4 7 RM HA i34 GE XES 2 MIRAGARE DIAP CI ME i21 i28

S STEM X SY DR

i3 2 C&

4

6

3

TRIM LIPO

3

H30

H32 ING BL

T LIN ENT TRUS INSU PEND ES

5

ET 2 DE DIAB

i7 ETHI

3

3

20

H33 P C+ H31 LDERMA GA

2

2

K GS AFÉ C

H22 LLAS UCTS FE OD PR 23 H

& EA FÉ AR CA ING AT SE

5

3

AC

NTS

B89

L ISTO

10

CITY LLEG CO

5 OF BR E

DI ME

4

B82

PR TA 3 RE

B84 OSPE IL

HD

3

3

N LEXO

CY MA SS OR AR NE RAT CE PH USI ELE REN B CC FE A ON ND ICS B83WINLA TRON A80 C EC CT EL

4

B88RA UNTA CO

H IVE CAL CY i24 HOLD DR DI ASDA 4 ME H6PHARMANERS / 5 PART H21 BANDSKIN 2 3 A 3 LEO 4 SE ERMO GS TH AEMP i4 COCI H12A&D DICA NI i1 4 4 3 FARM i5 AG ME 3 H G ACUM L H10TREE ININ PEAC CA ER ER SILV GINE EN

PH

i10 ODEMARMA

2

6

6

RE NICA MA

7

3

8

S

EC AL CONNFOR HE

A70DOH NHTING TH

3 4

A68

M & RU AL FO IC ES IN IC CL ERV S

A28

RX CAM

8

8

3

X HELI

3

A10 PG MA IN AI SLE

i52

2

2

i40

3 5

B80 GEN B79 KLS A UN CARE ETHI 8 5 FORT ALTH 4 7 HE 8 6 8 0 IL C8 C8 3 RETA S 2 Y LACH CY S CSY STEM A58 5 R+ B71 3 SY WIL ARMATION LEC L MPAN D86 GE KEN PH LU Y CO DICA SO S ARMA EA S 3 D84 RBIN HA WER 5 MT PH 7 EM B69UROLOG 6 ME TATE C8 DU 2 77 P DIES B68 60 S GROU ME 8 14 2 B 9 S B66SUCUP a ER PH 4 2 5 6 A48 STORE SS L TION 5 B67 60 LOW AD N NE E VITA NOVA 7 ME HNSO B65MYO B NF CAL SAFE SI AG IN SU DI BU JO 3 E LD 6 ELVE 6 STOR D88 3000 D80 HO 1 B64 61 YROS TS ME CY DISH 3 C7 B NE UC MA 5 ME 5 C7 SET ICS / HOPRODD 3 B50 PHAR B63 KEITO ING LT DEE GIST 6 YS A38 SEI LO 7 S 62 AD S KEON UCTS D82 7 KO MA SBUR FERN ON B AL TRTES 4 NU 7 RE LI 3 LVER UCTI 4 MC OD AR K) SAIN B53 IGEN LIANCECAL PH (U EC7 CITY RINT E8 PR 5 K GY 7 6 10 RE DI 2SI OD 3 SP BOTI LO 13 C7 REST C6 PR B RO CHNO B52 ME B40 6 FO BS 3 TS AL TE B54 RON LA C6 OYDS ERCI 8 6 ARD OM 8 LL MM 7 7 NW E8 RE CO 2 5 DE CA 1 L LS D70 10 C6 ALTH ME ER IPS 9 6 ECIA RY DICA HE HO 3 PFIZ 0 C6 ME SP TO LS AT D E8 BE 5 THE BORA TICA B44 AM OUP 4 ILME C6 RIS UCTS GR F8 NE 5 TUM EU 4 LA ENNA 3 AN CA C5 PROD 3 IC 5 RSE 2 QU ARMA 3 0 AV HO PS PH B30 T 9 AN 6 2 TE IFIC 8 AR C5 C4 RSEMCT 4 B34 0 ERCU WHI IENT 3 C5 BY ST NO RE 9 F9 BUTT AINING4 3 IVE D60 SC PLANETALTH DI BA 1 N TR RTAT C5 HUCO SILENCEMUSIC C43 NSENS TERS HE 5 14 Y 2 THE -OPE MACY EA S S OF 1 HA OPFIT LABS E 4 ALTH CO AR 36 D61 / VA SH CY PH B HING TANT C4 HE PE RIDG 2 3 NO TIVE TC 0 TH OR 3 EURO 3 9 ARMA KE HU NSUL 0 F8 D66 CN CREALLICIG PH D56 F7 HEAL 7 2 5 5 CO 5 C4 2 T CLAR L AL N 1 INTE DI C4 C3 OFOO G84 PIRE 5 52 ENT IONA ON ATIO OP AT D NS MO P 4 US 5 PR 6 T SH NATI SOCI 4 G87 BEE CLEM TERN OU S 4 6 PL 0 3 AS DR D IN 4 GR 5 BAPTTTER C3 LIANCECAL DE 4 U LT B20 6 FI 4 DER 3 RE 3 DI 0 C3 AN 2 G85 TTERYO 3 ME 3 E6 D59 3 D40 IDIS 8 SANT BE 6 0 3 ED 3 ALT 2 4 C3 RSAFE F7 OM C3 RIANCE D54 F7 5 OT G92 LELO 4 TA 6 G84 SCISKI 5 3 PR M 6 3 CAMBLIAN ALLE 6 R 3 TANI NES 5 OTS AL E6 RGICHE NO C3 OCS 6 0 S BO 4 RELI 4 5 OSVE TS E5 LES L 83 OP SU G81 C2 SU A 43 KI G GR UC LE 7 D AM 3 4 B10 D DR CHAR SSEL D41 SCIS 91 PROD 4 4 PH 5 2 RU LESA 5 4 9 4 G90 EC G S TS 5 3 T HO S S 10 F7 EX LTD GH 42 PRES ES LLOT & AL E-W TION 8 ONAL STIC SYS S LI IC 3 L TI LU JAYTGLASS D EX 0 L Y ON 6 ING C2 TRAD P 4 -MDS LEYS YS PR SO G82 RP PERS AGNO 3 TNT SERV ARMA F6 OYDY MACY E5 MEDICAOFESSI TANC G73 DICA NEER B9 GROU DI PH CE RE LE WDS LE TIVE SAFE LL AR 2 ME GI 0 MA WDS POSI PR NSUL PH 4 INDA 3 5 LIAN THCA a TH EN 3 Y 3 C2 CO AL RT E4 G86 b 4 G71 MAAND G73 HEALUCTS NE 3 2 INER HEAL 3 MA S D30 4 5 US G76N JO 9 5 S ISIS OD 3 6 DANO F62CUBED 5 0 AY CD LE PR H76 NTIC SONS FT 24 TIC RISE F6 E4 ND D AN MU S SA TING 6 5 ARCH 79 SCRA KINE TERP A1 M ATLA 3 b LIFE RGY RY MC HOLE 3 3 6 E4 TIVE ENTS EN LIGH 4 4 ALS 72 TAL- 2 G76P RESE G MEW 4 W F5 2 RD SYNE TH TO F6 UTIC 4 ACK G70 ILIPS NO CREA TAIL RONM a G VI 4 AFT 74a A GA 7 LITE 2 HEAL BORA D26 YB LTY 2 CE PH 0 RE LA VE 3 28 PA LOYA EMS 3 D6 SCAN G72DOSHI LAMACRING G MAST BV 3 6 IM ENVI E3 PHARMA EYEZ F5 ARMA D CAL SYST SHEL CO N ET ES S 5 RK 9 ER H80 TISL PH 4 5 4 MA OP F5 MESM E3 TA NOLOGI G72SONS & KE MARK 74a G77 ARMA AL EUTI S TURE M NU 3 G60 CAFLON IN 2 3 5 4 S PH 4 IS CH G GLOB ARAC TION CY 6 NA DREA 6 F5 RB G67 3 TE D H83 ILLY N PARK PH LU 20 MA Y F5 E3 L CARE a STIE 10 LT SO D 4 STAR UK 4 PHAR TANC 4 HT SP SPOO 11 4 PAK 4 4 G74 ALTH G75 CHRI VOGE BS D12GERMGIENE 0 STLIG & CO THE NSUL 3 AN HE 75 CIST KOOL G61 3 RM LA F4 A. HY BREA 3 GIC 8 MA 4 IER 56 CO 2 FIRST G GP ES HA G62 a E 5 S 5 6 F4 PHAR PPORT E2 DILO LI EM G ON IN TRAP LS 4 ME 3 PR TH TS AL SS D SU 4 SUPP 2 2 IN G64 HE G61NIGHTLVERS ECIA ODUC G50 MORI ARX 2 OL 1 ION F4 LABC 2 3 S LI 3 M SP 4 G57 PR VIE 8 AL S H70 TE F3 ABC TRIT AM DE 3 E2 MYTO G66 DIAN 5 D10 BC N MA 52 US E2 OB ORIE NU S H72 HOLD GL PL VIRI 63 BENH CITORS SO 8 ULTI IL ON FACT 3 AM ES 58 TIVA G MODI G DE SOLI F3PATTER 3 3 4 0RETA LUTI 2 GH PPLI KENTALS L G AC 6 4 TTIN B SU WAY IC 4 DICA S E2 ET 4 F3 SO T DE D T TEST TA AL NO 8 40 4 AS MA UN 6 L RE 3 2 G CEUT TERN S REHA & JS ME PPLIE AIG ANARD IMMU METIC L 3 OT UTIC 5 F3 LLMO THCA F3TALAR 3 TOPL 8 H73 CH G43 R IN CY 67 ELLI 2 4 ARMA 9 NERA MACEL G41 OP G59 SU CR HAYW DO DICA ICES OU ARMA H D PH 3 MI HEAL BU CHUR IGHT ING I ME 34 R PH BY 2 E LT NO 0 GE PHAR CI DW G MA H71 D KIW H60 SERV E F3 TRAD3 G54 Y BA G42WATER BY 3 E1 COUN 3 i73b CY L 2 3 MB T 62 BRAENANC 3 RE CYAN UK 4 5 MO PPOR H NCIALITY MY BA a 44 ERTS CARE URA ARMA 32 T FI ITT SER STO UTE CY SU 65 MA 1 E G 64 G NT 2 IT 0 2 TE 3 PD H MIST PH ES 6 FINA SIBI E H G39 DLEY 2 RECK NCKI LAMB ALTH E1 FLAM ALTH F2 INST PHAR GEME 3 DU NT BE i73 OPUSRVIC i7 VI ERSKINODUCTSD H57 52 TUK HE OF NA 3 G46 CIG HE NTE CARE G30 OODS HU H AP H66 ODS 63 9 PR LT AL SE MA NE SA TH NU 39 i7 FO LW 3 H PA AL PTY G IO UK F6 ORE-LI ATUR 4 4 HAZE SUMAHOLE H61 2 2 3 i75b G37 ME FR INT ES G45 HE H58 KORA GMBH W SH FIX ON VE 3 7 8 4 H46 THPO LOGI 3 HELI LIES 54 ED i78b RO G38 ONS S AU’SO UK 2 i75 DI AL H PP AP 3 NO TT LUTI RIOR SYMP 3 5 2 SU 2 REDM TELL i60 ME UK 4b H44 S HE TECH E SO INTE IFE 3 3 VV H59 PIVO P G36 STOR ERS & 35 IC DI4L i78 HOLD FE’S 3 A H47 M 18 CPPE OU 4 G SA EF RE 3 0 ME PD G 2 i5 MO ARMA 3 H56 DX GR H45 A JD 2 3 ENCE OPFITT i61 F1 O’KE 3 3 RES b L 3 ID SH 33 TENTS D PH 5 M 3 PH H41 ECIA UCTS i55 NP 36 N CONF GUARD NATU G PA LT 3 2. SP D OD I RE 3 H 4 3 b 2 3 3 i62 BUY PERSPI- 4 i48 AI ’S 4 CAL PR H4 4fx THCA TEAL 3 G28 SYSHOP 4 G H40 MEDIICES TA H34 S- H37 ALIA RE 2.5 HEAL 1 EA /7 DICA IN 6 RAMA TU UK S RE PH MY CARE NAL TS RV 9 ON O NA ME CKAG i5 X 5 AS AR SE 4 G6 CROS ALTHCA G28 NCLAIRMA 24 ALTH ATI i4 PHARMA 2 PLUS FOODODUC 2 NELS i64 PA H42 LOGIPHARMA 3 i4 5 HE 4 HE INTERN D PR 4 4 SI AR T 5 L 2 IS PH H35YSPEX 4 LIGH IONA D G22 SMART G8HaB RNAT H26 ERME READ 2 3 TE W ND IN 4 H24 LE PO 3 EVIL G9MEDIBA 27 ERSON 3 3 MAND H29 RA H ND P D HE OU 2 MH 25 GR G10 ALTHAI H IRIT HE 3 SP LTD 3 4

i58PHARME

SI 3 N- 2

LD HO

3

TR EN

CE AN

Media partners

Supported by

their margins

Q & A WITH MATTHEW BUTLER

INCLUDING WHAT’S NEW FOR 2012

Continued on page 2

It means that pharmacists are wasting valuable hours each week sourcing product, time that could more usefully be

T

É AF i20

The group of MPs concluded that the main cause of shortages was the export of medicines intended for the UK market to other countries in the EU, and called for a “renewed sense of urgency” among those responsible for the medicines supply chain.

JOHN D’ARCY, MANAGING DIRECTOR, NUMARK.

For more information, please turn to page 5

The situation has been exacerbated by the quota system, he says. “These quotas have been imposed by manufacturers without discussion or agreement, and are the greatest cause of frustration and inconvenience to pharmacists attempting to fulfil their supply obligations. Quotas combined with DTP and reduced wholesaling models not only reduces the availability of stock in the market, but also choice and competition.”

HIM! UK RESEARCH

CONSUMERS BUYING BEHAVIOUR AND MOTIVATIONS IDENTIFIED

The problem isn’t new, says John D’Arcy, Managing Director of Numark. “Since 2007, manufacturers have been controlling supply and protecting their margins via the Reduced Wholesalers or Direct to Pharmacy (DTP) models.”

“This is a great opportunity to engage with a high number of experts in pharmacy and raise the profile of our Consumer Healthcare division, highlighting our commitment to education and training for all pharmacy staff,” says Thompson.

Parallel export is a legal via the Reduced activity under EU trade laws, Wholesalers or Direct and indeed, no one objects to importing medicines to to Pharmacy (DTP) the UK, as D’Arcy point out: models.” “We live in a competitive world and parallel export John D’Arcy is entirely consistent with European free trade law. We’ve always been happy to have other countries’ products in the UK, we’re just not so happy when it comes to exporting goods.”

The company will also be sponsoring the show cafe area as well as one of the sessions in the OTC Academy, which will focus on skincare and eczema in particular.

“This situation has been dragging on for so long now, that people have started to accept it. Our only saving grace is that in most cases the shortage of supply amounts to an inconvenience, rather than “Since 2007, a life of death situation. But manufacturers have this state of affairs is not been controlling good for anyone; not for the industry and certainly not for supply and protecting the patient.”

“Our key aim is to support all of the pharmacy team as each member has a role to play in engaging with patients. We will be at the show to explain how our products work and help pharmacists and counter assistants to select the right product for the right patient by asking the right questions,” says Caroline Thompson, Expert Education and Events Manager at GlaxoSmithKline Consumer Healthcare UK. spent assisting patients, he says.

The results of last month’s report by the All Party Pharmacy Group (APPG) Inquiry may have come as a shock to the public, but it only confirmed what the pharmacy industry has known for some time; that patients in England are suffering because of a shortage in some NHS prescription medicines.

The Pharmacy Show will be the first time that many in the trade will have the opportunity to see the complete consumer healthcare offering. To give pharmacists a greater understanding of the full range of products and services on offer, expert field teams from GlaxoSmithKline will be available on the stand to talk about the science behind the products and how they can be used in pharmacies.

The current position on supply shortages is disrupting patient care and must be resolved as a matter of urgency, says John D’Arcy, Managing Director of Numark.

SEE PAGES 8 - 11 SEE PAGES 6 & 7 SEE PAGE 4

GLAXOSMITHKLINE RETURNS TO THE PHARMACY SHOW

GlaxoSmithKline returns to the Pharmacy Show this year to showcase their new look GlaxoSmithKline Consumer Healthcare division and the re-launch in 2012 of their online education platform mypharmassist.co.uk.

JUNE 2012 www.thepharmacyshow.co.uk

this July, skincare products.

Turn to page 3

The Consumer Healthcare business brings together oral care products, overthe-counter medicines, nutritional drinks, and from

MEDICINES SHORTAGES NEARING CRITICAL POINT

Latest Exhibitor News 2012 Exhibition Floor Plan

Pharmacy & Dispensary Design


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.